China Marketing Authorization Holder (MAH): Responsibilities for Drug Quality

After consulting on the draft in Nov. 2022, China National Medical Products Administration (NMPA) released the Administrative Rules on Supervising Dru…

Pharma
Feb. 20th, 2023

January 2022: Global Cosmetic Regulatory Updates

This is a collection of global cosmetic regulatory updates, including cosmetic regulations in China, the EU etc. 🇨🇳China China NMPA Approves Three New…

Cosmetic
Feb. 10th, 2023

January 2023: Chemical Regulatory Updates in Europe and America

This is a collection of regulatory updates in Europe and North America, including EU REACH, UK REACH, and US TSCA. European Union & United Kingdom…

Chemical
Feb. 07th, 2023

January 2023: Chemical Regulatory Updates in APAC Region

This is a collection of regulatory updates in Asia-Pacific regions, including China REACH, K-REACH, Japan CSCL, etc. 🇨🇳China On January 13, 2023, Chin…

Chemical
Feb. 07th, 2023

China’s Good Pharmacovigilance Practices (GVP): Decoding PV Compliance in China

On May 13, 2021, China National Medical Products Administration (NMPA) released the Good Pharmacovigilance Practices (GVP), which has been effective s…

Pharma
Feb. 01st, 2023

China Issues a New Cosmetics Supplementary Testing Method: Five Imidazoline Drugs Involved

The new cosmetic supplementary testing method applies to five imidazoline drugs such as Tetrahydrozoline and Naphazoline in cream, lotion, liquid (wat…

Cosmetic
Jan. 19th, 2023

China CDE Answers Questions on Drug Application’s Electronic Submission and More

On Jan. 11, 2023, China Center for Drug Evaluation (CDE) released 10 Q&As, including nine questions on the electronic submission of drug applicati…

Pharma
Jan. 18th, 2023

FAQs for China REACH: how to comply with environmental management registration requirements?

The SCC-MEE released the fifth batch of 9 FAQs to help enterprises fulfill their obligations under the MEE Order No.12. With the MEE Order No.12 in ef…

Chemical
Jan. 16th, 2023

China Clinical Trial Application / Investigational New Drug Application Procedures

In July 2018, China optimized the clinical trial applications (CTA) / investigational new drug (IND) applications’ review and approval procedure…

Pharma
Jan. 13th, 2023

China NMPA Allows Self-Updating the Notified Ingredient Safety Information

NMPA’s general cosmetic notification information system has added a new function, which allows companies that meet specified conditions to update and …

Cosmetic
Jan. 13th, 2023
Ready to Ignite in 2024: REACH24H Set to Break Barriers and Build Competence
  • Contact Us
  • +1 703 596 8055
  • +86 571 87007555
  • customer@reach24h.com

Latest Events

Get Chinese Pharmacopoeia 2020 Edition

Get Chinese Pharmacopoeia 2020 Edition

ChemLinked Sustainability Portal: Shape a Sustainable Future Together

ChemLinked Sustainability Portal

COMBOX – China Food Compliance Intelligent System